Amphastar Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2018
Total Assets: $513.6M
Liabilities Breakdown FY2018
Total Liabilities: $149.2M
Asset Breakdown
Total Assets: $513.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $86.3M | 16.8% |
| Accounts Receivable | $52.2M | 10.2% |
| Inventory | $69.3M | 13.5% |
| Property, Plant & Equipment | $210.4M | 41.0% |
| Goodwill | $4.0M | 0.8% |
| Intangible Assets | $9.1M | 1.8% |
| Other Assets | $82.3M | 16.0% |
Liabilities Breakdown
Total Liabilities: $149.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $31.3M | 21.0% |
| Long-Term Debt | $49.1M | 32.9% |
| Other Liabilities | $68.8M | 46.1% |